| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/19/2007 | CN101039959A Compositions and methods for treating inflammatory disorders |
| 09/19/2007 | CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/19/2007 | CN101037674A Rebuilt gland virus containing BMP-7 gene and usage thereof |
| 09/19/2007 | CN101036782A The application and preparation of anti-inflammatory fused protein for restraining tumor necrosis factor |
| 09/19/2007 | CN101036773A Application of compound agent in the medicine for treating fracture, tracheitis and depression for human beings |
| 09/19/2007 | CN101036772A Compound Chinese traditional medicine for preventing and treating osteoporosis |
| 09/19/2007 | CN101036753A Health-care wine of Chinese traditional medicine and making method thereof |
| 09/19/2007 | CN101036751A Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
| 09/19/2007 | CN101036729A Biological selenium germanium peptide maggot jujube tea powder for preventing SARS |
| 09/19/2007 | CN101036727A Selenium germanium peptide jujube tea powder for preventing avian influenza |
| 09/19/2007 | CN101036715A Method for producing dicatamnus dasycarpus medicine |
| 09/19/2007 | CN101036706A Wine for promoting blood circulation by removing blood stasis and for eliminating rheumatism |
| 09/19/2007 | CN101036696A Medicine combination for curing orthopaedics disease and the method for preparing the same |
| 09/19/2007 | CN101036691A Health-caring product for improving bone density and immunity |
| 09/19/2007 | CN101036683A Compound Chinese traditional medicine for curing osteoporosis |
| 09/19/2007 | CN101036672A Rheumatic oil |
| 09/19/2007 | CN101036670A Medicine for treating cervical vertebra disease |
| 09/19/2007 | CN101036664A Application of Di-wu extractive monocase in the preparation of material of Chinese traditional medicine |
| 09/19/2007 | CN101036660A Estrogen gelatin medicine and the method for preparing the same |
| 09/19/2007 | CN101036646A Quassia wood total alkaloid and the medical function of the monocase alkaloid |
| 09/19/2007 | CN101036621A Foaming composition |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100338079C Diphosphonic acid derivatives and preparation process and application thereof |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/19/2007 | CN100337672C Medicinal composition for treating rheumatic diseases |
| 09/19/2007 | CN100337670C Pills for promoting blood circulation and removing obstruction in channels |
| 09/19/2007 | CN100337649C Medicine for treating rheumatic arthritis and its preparing method |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2259621C Isocoumarin derivatives and their use in medicines |
| 09/18/2007 | CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 09/14/2007 | CA2577352A1 Canine and equine collagen joint health supplement |
| 09/13/2007 | WO2007102770A1 Gsk-3 inhibitors for the treatment of osteoporosis |
| 09/13/2007 | WO2007102531A1 Pharmaceutical combination |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007102011A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007102008A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007101988A2 Use of tsg-6 for treating bone diseases |
| 09/13/2007 | WO2007101884A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 09/13/2007 | WO2007079199A3 Substituted bis-amide metalloprotease inhibitors |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | WO2005115354A3 Compositions and methods for bone formation and remodeling |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070213546 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 09/13/2007 | US20070213402 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | DE102006011359A1 Verwendung eines Kokain-Derivats Use of a cocaine derivative |
| 09/13/2007 | CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2645018A1 Pharmaceutical combination |
| 09/13/2007 | CA2644751A1 Gsk-3 inhibitors for the treatment of osteoporosis |
| 09/13/2007 | CA2644421A1 Use of vx-702 for treating rheumatoid arthritis |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832583A1 Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832582A1 Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832293A1 Remedy for cancer metastasis and cancer metastasis inhibitor |
| 09/12/2007 | EP1831199A1 Novel compounds |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1831174A1 Amide derivatives |
| 09/12/2007 | EP1830881A2 Combining therapies targeting multiple toll-like receptors and use thereof |
| 09/12/2007 | EP1830875A2 Il-15 antigen arrays and uses thereof |
| 09/12/2007 | EP1830863A2 Protein formulation |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830848A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 09/12/2007 | EP1830834A1 Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 09/12/2007 | EP1830831A2 Pharmaceutical formulations of gallium salts |
| 09/12/2007 | EP1575591A4 Heterocycles and uses thereof |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1351694B1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | CN101035791A Pyrrolo[1,2-D][1,2-4]triazine as inhibitors of c-JUN N terminal kinases (JNK) and P-38 kinases |
| 09/12/2007 | CN101035764A 4-trifluoromethoxyphenoxybenzol-4-sulfonic acids, method for the production and use thereof in medicaments |
| 09/12/2007 | CN101032616A Chinese medicinal herb composition for external use for quickly recovering muscle and ligament and the preparing method |
| 09/12/2007 | CN101032614A Chinese traditional composition for curing slow concrescence or non-concrescence of fracture and the preparing method |
| 09/12/2007 | CN101032610A Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation |
| 09/12/2007 | CN101032606A Chinese traditional composition for external use for curing periarthritis of shoulder |
| 09/12/2007 | CN101032582A External used medicine for bonesetting made of pure Chinese traditional medicine |
| 09/12/2007 | CN101032581A Fumigation-washing medicine for curing phlegm blockage stasis type arthritis and the preparing method |
| 09/12/2007 | CN101032580A Medicine for treating rheumatic diseases |
| 09/12/2007 | CN101032569A Drink medicine good for spine |
| 09/12/2007 | CN101032568A Medicine for treating osteoproliferation |
| 09/12/2007 | CN101032557A Fupian granulae and the preparing method |
| 09/12/2007 | CN101032556A Novel purpose of preventing and curing osteoporosis of double-pill agent composed of moutan bark |
| 09/12/2007 | CN101032549A Producing method of ointment for external use |
| 09/12/2007 | CN101032546A Medicine for dunking tendon |